期刊文献+

基于大数据的随机对照试验 被引量:2

Randomized controlled trial based on big data
原文传递
导出
摘要 我国医疗领域目前已积累了海量数据,如何利用大数据开展随机对照试验日益得到关注。本研究结合国外利用大数据实施随机对照试验的成功经验,从数据来源、研究对象和研究结局确定、干预措施、随机化方法、知情同意的实施等方面进行梳理总结,以期为国内未来开展相关研究提供借鉴。 A large amount of data has been accumulated in Chinese medical area. Problems as how to use big data to carry out randomized controlled trials have also been increasingly noteworthy. Through learning the successful experiences in conducting randomized controlled trials on big data from abroad, this article introduces the knowledge regarding sources of data, identification of research subjects and outcomes, interventions, methods of randomization and the implementation of informed consent, etc., all related to big data, hoping to shed light on studies of this kind, for the years to come in China.
作者 许璐 王胜锋 詹思延 Xu Lu;Wang Shengfeng;Zhan Siyan(Department of Epidemiology and Biostatistics,School of Public Health,Peking University,Beijing 100191,China)
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2019年第6期702-706,共5页 Chinese Journal of Epidemiology
关键词 大数据 电子医疗数据 随机对照试验 Big data Electronic medical records Randomized controlled trial
  • 相关文献

参考文献1

二级参考文献22

  • 1陈锋,杨世民.我国药物不良反应监测体系建设现状与存在的问题[J].医药导报,2006,25(5):486-488. 被引量:58
  • 2药品不良反应报告和监测管理办法[s].卫生部令第81号,2011.
  • 3崔燕宁.药物安全与药物警戒[M].北京:人民卫生出版社,2014:122.
  • 4Xia YY, Hu DY, Liu FY, et al. Design of the anti-tubercu- losis drugs induced adverse reactions in China National Tu- berculosis Prevention and Control Scheme Study (ADACS) [J]. BMC Public Health, 2010, 10:267.
  • 5Shang P, Xia Y, Liu F, et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China [ J ]. PloS One, 2011, 6(7): e21836.
  • 6Schneeweiss S, Avorn J. A review of uses of health care uti- lization databases for epidemiologic research on therapeutics [J]. J Clin Epidemiol, 2005, 58(4) : 323-337.
  • 7Klompas M, McVetta J, Lazarus R, et al. Integrating clini- cal practice and public health surveillance using electronic medical record systems[J]. Am J Prev Med, 2012, 42(6 Suppl 2) : S154-S162.
  • 8Platt R, Wilson M, Chan KA, et al. The new Sentinel Net- work-improving the evidence of medical-product safety [ J ]. N Engl J Med, 2009, 361(7): 645-647.
  • 9Forrow S, Campion DM, Herrinton LJ, et al. The organiza- tional structure and governing principles of the Food and Drug Administrationg Mini-Sentinel pilot program[ J]. Phar- macoepidem DR S, 2012, 21(S1) : 12-17.
  • 10Platt R, Carnahan RM, Brown JS, et al. The U.S. Food and Drug Administrationg Mini-Sentinel program: status and direction[ J]. Pharmacoepidemiol Drug Saf, 2012, 21 ( Sup- vll): 1-8.

共引文献24

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部